Expanding Delivery of an Evidence-based Weight-loss Intervention to Enhance Access and Reach Underserved Groups After TBI
Key facts
- Who runs it
- Baylor Research Institute
- Where
- Dallas, United StatesSee the site
- Trial code
- Status
- Active, not recruiting
- People taking part
- 85 people enrolled
- Started
- 25 May 2023
- Expected to end
- 31 Aug 2027
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Telehealth-delivered Group Lifestyle Balance for people with TBI (tGLB-TBI)
- Brain Health Group (BHG)
- Record updated
- 6 October 2025
Who can take part
- Age
- 18 years to 80 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- 18-80 years of age
- Greater than or equal to 6 months post traumatic brain injury (TBI)
- Moderate to severe TBI at time of injury
- Body Mass Index greater than or equal to 25
- Able to participate in physical activity
- Willing to use a tablet/computer/smartphone (either personal device or one provided by the research team)
Who cannot take part
- Contraindications to physical activity (e.g., uncontrolled hypertension, unstable angina, severe joint disease, uncontrolled vertigo/dizziness)
- Diagnosed with or taking medications for Type 2 diabetes
- Pre-existing diagnosis of an eating disorder
- Not fluent in the English language
- Low cognitive function
- Residing in a hospital, acute rehabilitation facility, or skilled nursing facility
- Self-reported pregnancy
Where in United States
- Baylor Scott & White Research InstituteDallas, United States
About the trial
What the trial wants to find out
The goal of this clinical trial is to extend the accessibility of the Diabetes Prevention Program Group Lifestyle Balance (DPP-GLB) modified for people with TBI (GLB-TBI) to reduce health inequities and reach a broad and diverse sample.
Read full original descriptionShow less
To increase the accessibility and reach of the GLB-TBI we will conduct a randomized control trial (RCT) to assess intervention efficacy of telehealth delivery of the GLB-TBI (tGLB-TBI). Results will provide a scalable telehealth weight-loss program that clinicians and community workers across the country can use to help people with TBI lose weight and improve health.
The 2 groups in the trial
- Telehealth GLB-TBI (tGLB-TBI)Treatment being tested
The goal of the tGLB-TBI program is to help the participant achieve and maintain a 5-7% weight-loss using a two-pronged approach: 1. Physical activity: This is based upon recommendations by the American Heart Association and the American College of Sports Medicine (ACSM) to achieve 150 minutes of moderate intensity activity each week. Walking is the primary activity recommended. 2. Healthy eating: Based on United States Department of Agriculture guidelines, the GLB emphasizes healthy eating patterns and tracking dietary intake. The tGLB-TBI was modified from the DPP-GLB and is a one-year program with 22 sessions. It begins with 12 weekly sessions called the Core Program, followed by a Transition phase consisting of 2 bi-weekly and 2 monthly sessions, and a Support Phase consisting of 6 monthly sessions. Sessions will be delivered in a group setting via telehealth (Microsoft Teams).
Treatment: Telehealth-delivered Group Lifestyle Balance for people with TBI (tGLB-TBI)
- Brain Health Group (BHG)Existing treatment, for comparison
The Brain Health Group (BHG) meets at the same frequency as the GLB-TBI (i.e., 22 group-based sessions, 12 weekly, 4 bi-monthly, and 6 monthly).The focus of the BHG is on brain health education, self-management, and problem-solving and the BHG did not receive any education on weight-loss strategies. Sessions will be delivered in a group setting via telehealth (Microsoft Teams).
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 6 October 2025